Christine M. Lovly

<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers

Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.4K citations

Version 3.2022, Advanced Lung Disease, Medicine +15

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2021 · 990 citations · Full text

Non–Small Cell Lung Cancer, Version 4.2024

Gregory J. Riely, Douglas E. Wood, David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network · 2024 · 614 citations

Tumor Biology, Actionable Molecular Biomarkers, Advanced Lung Disease +14

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado et al. · Nature Communications · 2016 · 558 citations · Full text

Immunology, Immunologic Mechanism, Melanoma-specific Mhc-ii Expression +20